Diomed v. Total Vein Solutions
This article was originally published in The Gray Sheet
Executive Summary
Patent suit is filed over varicose vein endovascular laser treatment, Diomed says April 5. Separate actions are pending against AngioDynamics and Vascular Solutions (1"The Gray Sheet" Dec. 22, 2003, p. 6)...
You may also be interested in...
AngioDynamics Foresees New Laser Sales Opportunities With Sotradecol Drug
AngioDynamics expects to expand into hitherto untargeted markets with the help of its newly licensed Sotradecol drug for the treatment of small, uncomplicated varicose veins
Litigation In Brief
Medinol v. Boston Scientific: Injunction against sales of Boston Scientific Express stents and 30% royalty payments to Medinol on Taxus drug-eluting stents applies only to The Netherlands, Hague district court rules. Court finds device infringes one Dutch counterpart of four European patents asserted by Medinol. Boston Scientific, which will appeal the decision, notes that "neither the injunction nor potential damages will be material," because total 2003 sales of the devices in The Netherlands will be only about $10.6 mil. Meanwhile, Medinol's request for cross-border relief in 16 European countries is denied. The ruling follows a June 24 Dusseldorf, Germany district court finding that Boston Scientific infringed Medinol patents in that country (1"The Gray Sheet" June 30, 2003, p. 22). Related New York federal court litigation between the firms is ongoing (2"The Gray Sheet" Dec. 8, 2003, p. 23)...
Can Organovo Leverage Its Solid Phase II Data In MASH?
Cash-limited Organovo has an FXR agonist showing competitive efficacy and tolerability in MASH, but may need a partner to move forward in that disease as it may be prioritizing its IBD program.